URAHP (Gene)

Description:urate (hydroxyiso-) hydrolase, pseudogene

Predicted to enable hydroxyisourate hydrolase activity. Predicted to be involved in allantoin metabolic process; purine-containing compound catabolic process; and urate catabolic process. Predicted to be active in peroxisome. [provided by Alliance of Genome Resources, Apr 2022]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View URAHP's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with URAHP.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using URAHP.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for URAHP.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with URAHP.

Results found

Linked to

	Label	Description
	GSE195663 cisplatin 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE149632 dopamine 0 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE205714 GSE229013 adenosine 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE197571 FOXM1 RNF112 overexpression MGC-803 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE85880 GSE85881 tretinoin cardiac muscle cell 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE161897 MBNL knockout 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE119978 GSE180930 cisplatin 3 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE183327 GSE183328 DDIT3 overexpression 3 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE178292 melphalan 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE197092 SNRPE knockdown SMMC-7721 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS

GSE195663 cisplatin 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE149632 dopamine 0 v 6 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE205714 GSE229013 adenosine 3 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE197571 FOXM1 RNF112 overexpression MGC-803 2 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE85880 GSE85881 tretinoin cardiac muscle cell 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE161897 MBNL knockout 2 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE119978 GSE180930 cisplatin 3 v 7 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE183327 GSE183328 DDIT3 overexpression 3 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE178292 melphalan 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE197092 SNRPE knockdown SMMC-7721 1 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.